Christopher Gibson insider trades

Open-market stock purchases and sales by Christopher Gibson, Director at Recursion Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 20, 2021.

Recent trades

DateStockTradeValue
Jun 5, 2026RXRX Recursion Pharmaceuticals, IncSold$145K
Jun 5, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Jun 3, 2026PACB Pacific Biosciences of California, IncBought (not open market)—
May 22, 2026RXRX Recursion Pharmaceuticals, IncSold$123K
May 22, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
May 15, 2026RXRX Recursion Pharmaceuticals, IncSold (not open market)$69.4K
May 7, 2026RXRX Recursion Pharmaceuticals, IncSold$135K
May 7, 2026RXRX Recursion Pharmaceuticals, IncSold (not open market)—
May 7, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Apr 22, 2026RXRX Recursion Pharmaceuticals, IncSold$144K
Apr 22, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Apr 8, 2026PACB Pacific Biosciences of California, IncBought (not open market)—
Apr 8, 2026PACB Pacific Biosciences of California, IncBought (not open market)—
Apr 7, 2026RXRX Recursion Pharmaceuticals, IncSold$124K
Apr 7, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Mar 23, 2026RXRX Recursion Pharmaceuticals, IncSold$130K
Mar 23, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Mar 9, 2026RXRX Recursion Pharmaceuticals, IncSold (not open market)—
Mar 9, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Mar 3, 2026PACB Pacific Biosciences of California, IncBought (not open market)—
Mar 3, 2026PACB Pacific Biosciences of California, IncBought (not open market)—
Feb 19, 2026RXRX Recursion Pharmaceuticals, IncSold$138K
Feb 19, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Feb 17, 2026RXRX Recursion Pharmaceuticals, IncSold (not open market)$95.2K
Feb 6, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—

Companies traded

  • RXRX Recursion Pharmaceuticals, Inc: 203 sales, last Jun 5, 2026
  • PACB Pacific Biosciences of California, Inc: other filings, last Jun 3, 2026

Get free alerts when Christopher Gibson files a new trade →